In addition, BRCA1/2, ATM, BRIP1, PALB2, RAD51C, and RAD51D gene mutations are reported to be associated with high risk of ovarian cancers, and from the results of tumor tissue, it is easy to further determine their genetic status. This evidence concerns the gene RAD51D and ovarian cancer.